Switching to faricimab in cases of limited response to aflibercept in patients with neovascular age-related macular degeneration – report of two clinical cases
Ophthalmology · 25.05.2026 · 29 (1) · 17-20
DOI: 10.5114/oku/221517 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ophthalmology, online erschienen am 25.05.2026. Verfasst von Mateusz Raniewicz und 3 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Age-related macular degeneration is the leading cause of vision loss among elderly patients. Treatment for the exudative (neovascular) form of age-related macular degeneration involves intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) agents. However, this therapy is long term and burdensome, and therefore new substances and treatment regimens are being sought. According to scientific reports and real-world clinical observations, switching to a different drug during treatment is beneficial for many patients. This paper presents two clinical cases in which switching medications during anti-vascular endothelial growth factor therapy proved beneficial both functionally and morphologically.
Zitieren
APA
Raniewicz, M., Grudzień, M., Święch, A., & Mackiewicz, J. (2026). Switching to faricimab in cases of limited response to aflibercept in patients with neovascular age-related macular degeneration – report of two clinical cases. Ophthalmology, 29(1), 17-20. https://doi.org/10.5114/oku/221517
Vancouver
Raniewicz M, Grudzień M, Święch A, Mackiewicz J. Switching to faricimab in cases of limited response to aflibercept in patients with neovascular age-related macular degeneration – report of two clinical cases. Ophthalmology. 2026;29(1):17-20. doi:10.5114/oku/221517
BibTeX
@article{Raniewicz2026,
author = {Raniewicz, Mateusz and Grudzień, Monika and Święch, Anna and Mackiewicz, Jerzy},
title = {Switching to faricimab in cases of limited response to aflibercept in patients with neovascular age-related macular degeneration – report of two clinical cases},
journal = {Ophthalmology},
year = {2026},
volume = {29},
number = {1},
pages = {17--20},
doi = {10.5114/oku/221517}
}
EUVIMED